Edition:
United States

Vericel Corp (VCEL.OQ)

VCEL.OQ on NASDAQ Stock Exchange Capital Market

12.59USD
4:00pm EDT
Change (% chg)

$0.37 (+3.03%)
Prev Close
$12.22
Open
$12.25
Day's High
$12.88
Day's Low
$12.25
Volume
336,302
Avg. Vol
295,106
52-wk High
$15.20
52-wk Low
$3.30

Latest Key Developments (Source: Significant Developments)

Vericel Reports Q1 Loss Per Share Of $0.21
Tuesday, 8 May 2018 07:00am EDT 

May 8 (Reuters) - Vericel Corp ::VERICEL REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.21.Q1 REVENUE $18 MILLION VERSUS I/B/E/S VIEW $16.8 MILLION.Q1 EARNINGS PER SHARE VIEW $-0.13 -- THOMSON REUTERS I/B/E/S.AS OF MARCH 31, 2018, COMPANY HAD $29.8 MILLION IN CASH COMPARED TO $26.9 MILLION IN CASH AT DECEMBER 31, 2017.  Full Article

Vericel Q4 Revenue Rose 41 Pct To $23.4 Mln
Monday, 5 Mar 2018 07:30am EST 

March 5 (Reuters) - Vericel Corp ::VERICEL REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2018 FINANCIAL GUIDANCE.Q4 EARNINGS PER SHARE $0.01.Q4 REVENUE ROSE 41 PERCENT TO $23.4 MILLION.EXPECTS TOTAL NET PRODUCT REVENUES FOR FULL YEAR 2018, EXCLUDING ADDITIONAL LICENSE REVENUE, TO BE IN RANGE OF $73 MILLION TO $78 MILLION.  Full Article

Vericel Initiates Collaboration with Innovative Cellular Therapeutics
Tuesday, 2 Jan 2018 08:00am EST 

Jan 2 (Reuters) - Vericel Corp ::VERICEL CORP - ‍INITIATION OF LICENSE AGREEMENT WITH INNOVATIVE CELLULAR THERAPEUTICS FOLLOWING RECEIPT OF $5.1 MILLION UPFRONT,WARRANT PAYMENT FROM ICT​.VERICEL - ‍UNDER DEAL,ICT WILL DEVELOP,DISTRIBUTE MACI EPICE,IXMYELOCEL-T,CARTICEL IN GREATER CHINA,SOUTH KOREA, SINGAPORE, OTHER COUNTRIES IN REGION​.  Full Article

Vericel Enters Into Expanded $25 Million Debt Facilities With Silicon Valley Bank And Midcap Financial
Thursday, 7 Dec 2017 08:00am EST 

Dec 7 (Reuters) - Vericel Corp ::VERICEL ENTERS INTO EXPANDED $25 MILLION DEBT FACILITIES WITH SILICON VALLEY BANK AND MIDCAP FINANCIAL TO SUPPORT ACCELERATING MACI UPTAKE AND INCREASED EPICEL USAGE.VERICEL-ENTERED INTO EXPANDED $15 MILLION TERM LOAN, RETAINED EXISTING $10 MILLION REVOLVING LINE OF CREDIT WITH SILICON VALLEY BANK,MIDCAP FINANCIAL SERVICES​.  Full Article

Vericel reports Q3 loss per share $0.16
Tuesday, 7 Nov 2017 07:00am EST 

Nov 7 (Reuters) - Vericel Corp :Vericel reports third-quarter 2017 financial results.Q3 loss per share $0.16.Q3 revenue $14.3 million versus I/B/E/S view $13.9 million.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.Vericel Corp - ‍As of September 30, 2017, company had $15.5 million in cash compared to $23.0 million in cash at December 31, 2016​.  Full Article

Vericel Q2 loss per share $0.07
Wednesday, 9 Aug 2017 07:00am EDT 

Aug 9 (Reuters) - Vericel Corp ::Vericel reports second-quarter 2017 financial results.Q2 loss per share $0.07.Q2 revenue rose 32 percent to $17 million.Q2 revenue view $12.9 million -- Thomson Reuters I/B/E/S.Q2 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article

Vericel Corp enters distribution agreement with Orsini Pharmaceutical Services
Friday, 19 May 2017 04:13pm EDT 

May 19 (Reuters) - Vericel Corp :Co entered distribution agreement with Orsini Pharmaceutical Services Inc to appoint Orsini as specialty pharmacy distributor of Carticel.Initial term of distribution deal shall end on May 15, 2019, parties may renew distribution agreement for two additional two-year terms.  Full Article

Vericel Q1 loss per share $0.31
Wednesday, 10 May 2017 07:00am EDT 

May 10 (Reuters) - Vericel Corp :Vericel reports first-quarter 2017 financial results.Q1 loss per share $0.31.Q1 revenue $9.4 million.Q1 earnings per share view $-0.14 -- Thomson Reuters I/B/E/S.Q1 revenue view $14.4 million -- Thomson Reuters I/B/E/S.  Full Article

Vericel enters into license agreement with Innovative Cellular Therapeutics
Wednesday, 10 May 2017 07:00am EDT 

May 10 (Reuters) - Vericel Corp :Vericel Corp - entered into a license agreement with Innovative Cellular Therapeutics for development, manufacturing and commercialization of Vericel product portfolio.VERICEL - ICT will acquire exclusive rights to develop and distribute carticel, maci, ixmyelocel-t, and epicel in Greater China, South Korea, Singapore, and other countries in region.Says under terms of license agreement, Vericel will receive an upfront payment of $6.0 million.Says in addition, Vericel is eligible to receive about $8.0 million in development and commercial milestones.  Full Article

Vericel Q4 loss per share $0.34
Friday, 10 Mar 2017 07:15am EST 

Vericel Corp : Vericel reports fourth-quarter and year-end 2016 financial results . Q4 revenue $16.5 million versus i/b/e/s view $16.1 million . Q4 loss per share $0.34 . Q4 adjusted non-gaap loss per share $0.14 .Vericel - as of dec 31, 2016, co had $23.0 million in cash and cash equivalents compared to $14.6 million in cash and cash equivalents at december 31, 2015.  Full Article